Central Asia Lumeichun Biotechnology Inc.

Central Asia Lumeichun Biotechnology Inc.

OOTC:ZYLM
0.18
USD
0.00
(0.00%)
-303.74EPS
157.76BMarket Cap

Latest Stock Split

Jul 28, 2026

1:500

For every 500 shares held, investors received 1. The price per share adjusted from $0.00 to $0.45.

The split itself did not change the total investment value.

Use this split data in your app

Build with our data

Stock Split History

  1. Jul 28, 2026
    Before$0.00
    Split ratio1:500
    After$0.45
    Reverse
  2. Jan 12, 2015
    Before$0.02
    Split ratio1:500
    After$11.00
    Reverse
  3. Mar 08, 2013
    Before$0.01
    Split ratio1:100
    After$0.60
    Reverse
  4. Jan 20, 2005
    Before$0.11
    Split ratio1:20
    After$2.20
    Reverse
  5. Jul 22, 2003
    Before—
    Split ratio1:400
    After—
    Reverse

About Central Asia Lumeichun Biotechnology Inc. stock splits

Central Asia Lumeichun Biotechnology Inc. (OTC:ZYLM) operates in the Movies/Entertainment industry.

Central Asia Lumeichun Biotechnology Inc. company overview

When did Central Asia Lumeichun Biotechnology Inc. stock split?

Central Asia Lumeichun Biotechnology Inc.'s most recent stock split was on July 28, 2026. It was a 1-for-500 reverse split, so shareholders received 1 share for every 500 they held.

What is Central Asia Lumeichun Biotechnology Inc.'s stock split history?

Central Asia Lumeichun Biotechnology Inc. (OTC:ZYLM) has split its stock 5 times: a 1-for-400 reverse split on July 22, 2003, a 1-for-20 reverse split on January 20, 2005, a 1-for-100 reverse split on March 8, 2013, a 1-for-500 reverse split on January 12, 2015, and a 1-for-500 reverse split on July 28, 2026.

How many times has Central Asia Lumeichun Biotechnology Inc. stock split?

Central Asia Lumeichun Biotechnology Inc. has split its stock 5 times. This history records 5 reverse splits between July 22, 2003 and July 28, 2026.

What is a reverse stock split?

A reverse stock split combines several shares into one and raises the price per share by the same factor, so the total value of a holding does not change. In Central Asia Lumeichun Biotechnology Inc.'s 1-for-500 reverse split on July 28, 2026, every 500 shares became one share. Companies often use reverse splits to lift a low share price, for example to keep meeting an exchange's minimum price requirement.

Will Central Asia Lumeichun Biotechnology Inc. split its stock again?

Central Asia Lumeichun Biotechnology Inc. has not announced a new split in our records. Its most recent split was on July 28, 2026, less than a year ago. Companies announce splits in advance, and any new OTC:ZYLM split will appear on this page.